The following government grants in the FederalGrants.com database contain the term housing in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839 |
PAR-18-683 |
| Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional) |
93.393 |
PAR-18-681 |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839 |
PAR-18-684 |
| Service Area Competition-Additional Areas (SAC-AA) - Anchorage, Alaska; Sarasota, Florida; and Perth Amboy, New Jersey |
93.224 |
HRSA-18-109 |
| Announcement for Program Funding for NRCS' Conservation Innovation Grants (CIG) for Federal fiscal year (FY) 2018 - Pennsylvania |
10.912 |
USDA-NRCS-PA-CIG-18-001 |
| NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required) |
93.855 |
PAR-18-679 |
| Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed) |
93.393 |
PA-18-677 |
| Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed) |
93.393 |
PA-18-678 |
| 2018 Evidence-Based Falls Prevention Program financed by Prevention and Public Health Fund |
93.761 |
HHS-2018-ACL-AOA-FPSG-0255 |
| 2018 Empowering Older Adults and Adults with Disabilities through Chronic Disease Self-Management Education Programs Financed by the Prevention and Public Health Fund |
93.734 |
HHS-2018-ACL-AOA-CSSG-0256 |
| Identify, Analyze, and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) |
93.061 |
RFA-TS-18-001 |
| U.S. Tobacco Control Policies to Reduce Health Disparities (R21 Clinical Trial Optional) |
93.395 |
PAR-18-674 |
| Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations An ORWH FY18 Administrative Supplement (Admin Supp - Clinical Trial Optional) |
93.121, 93.173, 93.242, 93.273, 93.279, 93.313, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.846, 93.847, 93.855, 93.865, 93.867 |
PA-18-676 |
| U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional) |
93.395 |
PAR-18-675 |
| Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54) |
93.113, 93.242, 93.273, 93.313, 93.847, 93.866 |
RFA-OD-18-004 |
| Announcement for Program Funding for NRCS' Conservation Innovation Grants (CIG) for Federal Fiscal year (FY) 2018 - California |
10.912 |
USDA-NRCS-CA-CIG-18-01 |
| SCA Academy Orientation Week - NPS Alaska Region |
15.931 |
NPS-DOIP18AC00186 |
| National Research Mentoring Network (NRMN) Coordination Center (U24 - Clinical Trial Not Allowed) |
93.310 |
RFA-RM-18-003 |
| National Research Mentoring Network (NRMN) Resource Center (U24 - Clinical Trial Not Allowed) |
93.310 |
RFA-RM-18-002 |
| National Research Mentoring Network: The Science of Mentoring, Networking, and Navigating Career Transition Points (U01 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-18-004 |
| Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional) |
93.847 |
RFA-DK-18-004 |
| Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01- Clinical Trial Optional) |
93.847 |
RFA-DK-17-025 |
| Exploiting Omics Assays to Investigate Molecular Regulation of Persistent HIV in Individuals with Substance Use Disorder (R61/R33 Clinical Trial Optional) |
93.279 |
RFA-DA-19-003 |
| Elucidating the Effect of Glycemic Excursions on Patient Well-being and Cognitive Status in People with Type 1 Diabetes (T1D) (R01 Clinical Trial Optional) |
93.847 |
RFA-DK-18-003 |
| Clinical, Behavioral and Physiological Research Testing Current and Novel Closed Loop Systems (R01- Clinical Trial Required) |
93.847 |
RFA-DK-17-023 |
| Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (T1D) (R01 Clinical Trial Required) |
93.847 |
RFA-DK-17-024 |
| Discovery of Early Type 1 Diabetes Disease Biomarkers in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 - Clinical Trial Not Allowed) |
93.847 |
RFA-DK-17-021 |
| High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-17-022 |
| The Characterization and Discovery of Novel Autoantigens and Epitopes in Type 1 Diabetes (R01 Clinical Trial Optional) |
93.847 |
RFA-DK-17-031 |
| Incorporating Patient-Reported Outcomes into Clinical Care for Type 1 Diabetes (R01 Clinical Trial Required) |
93.847 |
RFA-DK-17-027 |
| Funding For Collaborative Clinical Research In Type 1 Diabetes: Living Biobank (R01 Clinical Trial Optional) |
93.847 |
RFA-DK-17-032 |
| Clinical Validation of Candidate Biomarkers for Neurological Diseases (U01 Clinical Trial Optional) |
93.853 |
PAR-18-664 |
| Genetics of Alcohol Sensitivity and Tolerance (R01 Clinical Trial Not Allowed) |
93.273 |
PA-18-660 |
| Towards Implementing Novel Training Methods to Enhance Cognition in Aging (U01 Clinical Trial Required) |
93.866 |
RFA-AG-18-031 |
| Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes (R01 Clinical Trial Required) |
93.847 |
RFA-DK-17-028 |
| Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-17-020 |
| Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes Research (U01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-17-019 |
| Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed) |
93.393 |
PAR-18-654 |
| Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) |
93.393 |
PAR-18-655 |
| Announcement for Program Funding for NRCS' Conservation Innovation Grants (CIG) for Federal fiscal year (FY) 2018 - ME |
10.912 |
USDA-NRCS-ME-CIG-18-01 |
Search Results 6441-6480 of 17607
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 [Next] |
